Meloxicam is the recommended analgesic in the CWMP and is a non-steroidal anti-inflammatory drug (NSAID). But unlike the other NSAID medications that inhibit platelet function and can lead to increased bleeding risk, it is a preferential COX-2 inhibitor that spares platelet function so it does not interfere with hemostasis and is well-tolerated.